Want to see ENTX full AI Analyst Report?
Entera Bio (ENTX) Ratios
487 Followers
Entera Bio Ratios
ENTX's free cash flow for Q2 2026 was $-3.47M. For the 2026 fiscal year, ENTX's free cash flow was decreased by $-3.00K and operating cash flow was $-3.46M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.23 | 7.63 | 10.32 | 9.58 | 8.01 |
| Quick Ratio | 3.23 | 7.63 | 10.32 | 9.58 | 8.01 |
| Cash Ratio | 3.23 | 7.36 | 10.10 | 9.18 | 7.87 |
| Solvency Ratio | -3.95 | -7.25 | -6.41 | -9.47 | -3.55 |
| Operating Cash Flow Ratio | -3.35 | -5.80 | -6.70 | -9.32 | -2.87 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 4.22M | $ 7.66M | $ 9.88M | $ 11.48M | $ 21.91M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.04 | 0.03 | 0.04 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.04 | 0.03 | 0.04 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.22 | 1.16 | 1.13 | 1.12 | 1.15 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -417.41 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -421.28 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
| Net Debt to EBITDA | 0.58 | 0.88 | 1.21 | 0.95 | 2.02 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 4.97% | 0.00% | -23.13% | 34.68% |
| EBIT Margin | -27235.71% | -5263.54% | 0.00% | -9652.24% | -2139.58% |
| EBITDA Margin | -27164.29% | -5238.12% | 0.00% | -9604.48% | -2130.30% |
| Operating Profit Margin | -27450.00% | -5295.58% | 0.00% | -9752.24% | -2139.58% |
| Pretax Profit Margin | -27235.71% | -5263.54% | 0.00% | -9652.24% | -2144.66% |
| Net Profit Margin | -27235.71% | -5271.27% | 0.00% | -9754.48% | -2134.33% |
| Continuous Operations Profit Margin | -27235.71% | -5271.27% | 0.00% | -9754.48% | -2134.33% |
| Net Income Per EBT | 100.00% | 100.15% | 100.33% | 101.06% | 99.52% |
| EBT Per EBIT | 99.22% | 99.39% | 99.11% | 98.97% | 100.24% |
| Return on Assets (ROA) | -71.53% | -101.61% | -75.55% | -99.57% | -46.90% |
| Return on Equity (ROE) | -87.31% | -118.08% | -85.59% | -111.20% | -54.01% |
| Return on Capital Employed (ROCE) | -83.60% | -116.69% | -83.75% | -110.88% | -53.52% |
| Return on Invested Capital (ROIC) | -218.81% | -114.32% | -82.72% | -110.03% | -52.85% |
| Return on Tangible Assets | -71.53% | -101.61% | -75.55% | -99.57% | -46.90% |
| Earnings Yield | -12.77% | -11.95% | -51.07% | -62.15% | -16.54% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.19 | 1.44 | 0.00 | 0.54 | 3.12 |
| Payables Turnover | 0.09 | 1.30 | 0.67 | 9.71 | 2.25 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.31 | 0.55 | 0.00 | 0.59 | 1.45 |
| Asset Turnover | 0.00 | 0.02 | 0.00 | 0.01 | 0.02 |
| Working Capital Turnover Ratio | 0.01 | 0.02 | 0.00 | 0.01 | 0.04 |
| Cash Conversion Cycle | -1990.12 | -26.03 | -540.98 | 632.47 | -45.46 |
| Days of Sales Outstanding | 1903.21 | 254.09 | 0.00 | 670.07 | 116.98 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 3893.33 | 280.12 | 540.98 | 37.61 | 162.44 |
| Operating Cycle | 1903.21 | 254.09 | 0.00 | 670.07 | 116.98 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.16 | -0.18 | -0.25 | -0.43 | -0.35 |
| Free Cash Flow Per Share | -0.16 | -0.18 | -0.25 | -0.44 | -0.35 |
| Dividend Paid and CapEx Coverage Ratio | -68.88 | -2272.67 | -430.00 | -265.94 | -533.12 |
| Capital Expenditure Coverage Ratio | -68.88 | -2272.67 | -430.00 | -265.94 | -533.12 |
| Operating Cash Flow Coverage Ratio | -15.04 | -25.07 | -18.74 | -137.35 | -30.01 |
| Operating Cash Flow to Sales Ratio | -175.48 | -37.67 | 0.00 | -93.28 | -15.87 |
| Free Cash Flow Yield | -8.34% | -8.55% | -42.10% | -59.66% | -12.32% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -7.76 | -8.48 | -1.96 | -1.61 | -6.05 |
| Price-to-Sales (P/S) Ratio | 2133.59 | 440.99 | 0.00 | 156.94 | 129.07 |
| Price-to-Book (P/B) Ratio | 6.84 | 9.88 | 1.68 | 1.79 | 3.27 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -11.98 | -11.70 | -2.38 | -1.68 | -8.12 |
| Price-to-Operating Cash Flow Ratio | -12.16 | -11.71 | -2.38 | -1.68 | -8.13 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.44 | 0.06 | 0.38 | 0.47 |
| Enterprise Value Multiple | -7.27 | -7.53 | -0.77 | -0.68 | -4.04 |
| Enterprise Value | 82.99M | 71.43M | 6.78M | 8.81M | 49.11M |
| EV to EBITDA | -7.27 | -7.53 | -0.77 | -0.68 | -4.04 |
| EV to Sales | 1976.02 | 394.64 | 0.00 | 65.76 | 86.00 |
| EV to Free Cash Flow | -11.10 | -10.47 | -0.92 | -0.70 | -5.41 |
| EV to Operating Cash Flow | -11.26 | -10.48 | -0.93 | -0.71 | -5.42 |
| Tangible Book Value Per Share | 0.28 | 0.21 | 0.36 | 0.41 | 0.86 |
| Shareholders’ Equity Per Share | 0.28 | 0.21 | 0.36 | 0.41 | 0.86 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | -0.00 | -0.01 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Net Income Per Share | -0.25 | -0.25 | -0.31 | -0.45 | -0.47 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.01 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 142.95 | 24.86 | 0.00 | 43.16 | 11.86 |
| SG&A to Revenue | 131.55 | 28.15 | 0.00 | 0.00 | 9.96 |
| Stock-Based Compensation to Revenue | 65.48 | 14.12 | 0.00 | 16.77 | 3.26 |
| Income Quality | 0.64 | 0.71 | 0.82 | 0.96 | 0.74 |
Currency in USD
